Long-Term Outcomes From Re-Resection for High-Risk Non–muscle-Invasive Bladder Cancer: A Potential to Rationalize Use

European Urology Focus - Netherlands
doi 10.1016/j.euf.2017.10.004
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2011English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Systemic Inflammatory Markers and Oncologic Outcomes in Patients With High-Risk Non–muscle-Invasive Urothelial Bladder Cancer

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2018English

Serum microRNAs as Predictors of Risk for Non-Muscle Invasive Bladder Cancer

Oncotarget
Oncology
2018English

Mp58-05 the Long-Term Prognostic Value of Survivin Expressing Circulating Tumor Cells in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (Nmibc)

Journal of Urology
Urology
2018English

Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy

Urology
Urology
2010English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Prediction Tools in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Comment on “Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection”

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy